Adela Bio | Toronto, San Fransisco | A breakthrough approach to cancer detection [african american man using the computer and listening to headphones]

Congress presentations and publications

Congress Presentation
November 15, 2024
AACR Special Conference in Cancer Research
Biological insights into tissue-agnostic plasma cfDNA methylation signature for surveillance of head and neck cancer recurrence
Congress Presentation
September 14, 2024
ESMO 2024
Clinical Validation of a Tissue-agnostic Genome-wide Methylome Enrichment MRD Assay for Head and Neck Cancers
Publication
September 14, 2024
Annals of Oncology
Clinical validation of a tissue-agnostic genome-wide methylome enrichment MRD assay for head and neck malignancies
Congress Presentation
June 3, 2024
ASCO 2024
Performance characteristics of a tissue-agnostic genome-wide methylome enrichment MRD assay for head and neck malignancies
Congress Presentation
April 9, 2024
AACR 2024
Analytical performance of a genome-wide methylome enrichment platform to detect minimal residual disease from plasma-derived cell-free DNA
Congress Presentation
April 8, 2024
AACR 2024
The development of a tissue-agnostic genome-wide methylome enrichment MRD assay for applications across the cancer care continuum for head and neck malignancies
Publication
February 23, 2024
Cancer Discovery
Early Changes in Tumor-Naive Cell-Free Methylomes and Fragmentomes Predict Outcomes in Pembrolizumab-Treated Solid Tumors
Congress Presentation
November 30, 2023
MTCS 2023
Prognostic Performance of a Genome-Wide Methylome Enrichment Platform in Early-Stage Non-Small Cell Lung Cancer (NSCLC)
Congress Presentation
November 14, 2023
AMP 2023
Pre-Analytic Variables and Quality Controls for Robust Processing of Plasma-Derived Cell-Free DNA (cfDNA) Using a Whole Methylome Enrichment Platform
Congress Presentation
October 21, 2023
ESMO 2023
Prognostic Performance of a Genome-Wide Methylome Enrichment Platform in Head and Neck Cancer
Congress Presentation
October 21, 2023
ESMO 2023
Evaluation of a Genome-Wide Methylome Enrichment Platform for Circulating Tumor DNA Quantification and Prognostic Performance in Renal Cell Carcinoma (RCC)
Congress Presentation
April 16, 2023
AACR 2023
Development of a Genome-Wide Methylome Enrichment Platform for Multi-Cancer Early Detection
Publication
December 22, 2022
iScience
Cell-free DNA methylation-defined prognostic subgroups in small-cell lung cancer identified by leukocyte methylation subtraction
Publication
December 1, 2022
Neuro-Oncology
Cerebrospinal fluid methylome-based liquid biopsies for accurate malignant brain neoplasm classification
Publication
October 29, 2022
Nature Communications
The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumors
Publication
September 9, 2022
Cell Reports Methods
Sensitive and reproducible cell-free methylome quantification with synthetic spike-in controls
Publication
August 1, 2021
Clin Cancer Res 27 (15): pg. 230–4244 (2021)
Tumor-Naïve Multimodal Profiling of Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma
Publication
June 22, 2020
Nature Medicine 26, pg. 1041–1043 (2020)
Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes
Publication
June 22, 2020
Nature Medicine 26, pg. 1044–1047 (2020)
Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes
Publication
August 30, 2019
Nature Protocols 14, pg. 2749–2780 (2019)
Preparation of cfMeDIP-seq libraries for methylome profiling of plasma cell-free DNA
Publication
November 14, 2018
Nature 563, pg. 579–583 (2018)
Sensitive tumour detection and classification using plasma cell-free DNA methylomes
Adela Bio | Toronto, San Fransisco | A breakthrough approach to cancer detection [logo]
Toronto | san francisco
353 Hatch Drive, Foster City, CA 94404
info@adelabio.com

CLIA ID Number: 05D2297636
‍
COPYRIGHT ADELA, INC. 2024.
ALL RIGHT RESERVED.
‍
Please read our privacy policy and terms of use.
contact us
Thank you, Your submission has been received.
Something went wrong while submitting the form.
homeaboutpublicationsnewscareersterms of useprivacy policy